Extensior by Abbott and Novo Nordisk expands access to semaglutide therapy in India
Implications: Extensior catapults Abbott into the GLP-1 frenzy,...
March 31, 2026
Browse Category
News
Breaking developments shaping Indian pharma, biotech, and healthcare.
Fast, factual reporting on what just happened.
Updated continuously, without the clutter.
63 Articles
CDSCO to Issue Faster Testing NOCs for Drug Import and Manufacturing Applications
Key Highlights: Implications: Pharma innovators breathe easy as...
MSN Laboratories receives Central Drugs Standard Control Organisation approval for generic Semaglutide
Key Highlights: Implications: MSN joins the generics...
MSD Appoints Brecht Vanneste as Managing Director for India
Key Highlights: Implications: Oncology ace Vanneste...
Bayer’s Nubeqa Receives Expanded Approval in India for mHSPC with ADT
Key Highlights: Implications: Nubeqa’s India approval intensifies...
GSK Survey Highlights Shingles Awareness Gap Among Adults with Chronic Conditions in India
Key Highlights: Implications: Survey hands GSK potent ammo to...
Zydus Lifesciences to Launch Semaglutide Injection in India After Patent Expiry
Key Highlights: Implications: Zydus’ smart-pen assault...
Eris Lifesciences Partners with Natco Pharma to Commercialize Semaglutide in India
Key Highlights: Implications: Semaglutide generics could slash Novo...
Miraqules MedSolutions’s StopBleed Receives Class C Approval from CDSCO
Key Highlights: Implications: StopBleed fills critical...
Novartis AG to transfer 70.68% stake in Novartis India Limited to ChrysCapital
Key Highlights: Implication: This divestment signals multinational pharma...
Trending News
Stay Connected
Get Every Newsletter
Get notified of the best deals on our WordPress themes.